Starton Therapeutics (Starton Therapeutics) FCF Margin % : 0.00% (As of Jun. 2023)

View and export this data going back to 2050. Start your Free Trial

What is Starton Therapeutics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Starton Therapeutics's Free Cash Flow for the three months ended in Jun. 2023 was $-1.46 Mil. Starton Therapeutics's Revenue for the three months ended in Jun. 2023 was $0.00 Mil. Therefore, Starton Therapeutics's FCF Margin % for the quarter that ended in Jun. 2023 was 0.00%.

As of today, Starton Therapeutics's current FCF Yield % is 0.00%.

The historical rank and industry rank for Starton Therapeutics's FCF Margin % or its related term are showing as below:

STA's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -139.2
* Ranked among companies with meaningful FCF Margin % only.

Starton Therapeutics FCF Margin % Historical Data

The historical data trend for Starton Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starton Therapeutics FCF Margin % Chart

Starton Therapeutics Annual Data

Trend

Mar21

Mar22

Mar23

FCF Margin %

-302.20

Starton Therapeutics Quarterly Data
	Mar21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23
FCF Margin %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Starton Therapeutics's FCF Margin %

For the Biotechnology subindustry, Starton Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Starton Therapeutics's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Starton Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Starton Therapeutics's FCF Margin % falls into.

Starton Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Starton Therapeutics's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	-3.92	/	0
	=	%

Starton Therapeutics's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	-1.456	/	0
	=	%

Starton Therapeutics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Starton Therapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Starton Therapeutics (Starton Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starton Therapeutics Inc (NAS:STA) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

215 College Road, Suite No.300, Paramus, NJ, USA, 07652

Website

https://www.startontx.com

Starton Therapeutics Inc is a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, and longer. Starton's proprietary continuous delivery technology can increase the efficacy of approved drugs, make them more tolerable, and expand their potential use.

Starton Therapeutics (Starton Therapeutics) Headlines

No Headlines